Mercer Global Advisors Inc Abbott Laboratories Transaction History

Mercer Global Advisors Inc

$45.6 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $14 Million - $17.2 Million	155,535 Added 59.73%	415,935 $45.8 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $724,308 - $869,048	-7,582 Reduced 2.83%	260,400 $25.2 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $1.19 Million - $1.32 Million	11,784 Added 4.6%	267,982 $29.2 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $94,438 - $111,159	975 Added 0.38%	256,198 $25.9 Million
Q4 2022 Feb 08, 2023	BUY	$95.06 - $111.52 $2.74 Million - $3.21 Million	28,785 Added 12.71%	255,223 $28 Million
Q3 2022 Nov 15, 2022	BUY	$96.76 - $112.03 $1.25 Million - $1.45 Million	12,939 Added 6.06%	226,438 $21.9 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $2.34 Million - $2.83 Million	22,943 Added 12.04%	213,499 $23.2 Million
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $2.05 Million - $2.5 Million	17,949 Added 10.4%	190,556 $22.6 Million
Q4 2021 Feb 04, 2022	BUY	$115.53 - $141.46 $812,869 - $995,312	7,036 Added 4.25%	172,607 $24.3 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $1.65 Million - $1.83 Million	14,184 Added 9.37%	165,571 $19.6 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $1.1 Million - $1.3 Million	10,432 Added 7.4%	151,387 $17.6 Million
Q1 2021 Aug 10, 2021	BUY	$108.84 - $128.23 $298,983 - $352,247	2,747 Added 1.99%	140,955 $16.9 Million
Q1 2021 May 11, 2021	BUY	$108.84 - $128.23 $2.09 Million - $2.46 Million	19,214 Added 16.15%	138,208 $16.6 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $145,005 - $158,014	1,381 Added 1.17%	118,994 $13 Million
Q3 2020 Dec 10, 2020	BUY	$91.64 - $111.29 $808,997 - $982,468	8,828 Added 8.12%	117,613 $12.8 Million
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $1.08 Million - $1.39 Million	-14,156 Reduced 11.51%	108,785 $9.95 Million
Q1 2020 May 18, 2020	SELL	$62.82 - $91.86 $165,907 - $242,602	-2,641 Reduced 2.1%	122,941 $9.7 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $664,901 - $740,190	8,469 Added 7.23%	125,582 $10.9 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $9.58 Million - $10.4 Million	117,113 New	117,113 $9.8 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $6.34 Million - $7.4 Million	-87,058 Closed	0 $0
Q1 2019 Apr 23, 2019	SELL	$66.22 - $80.06 $274,150 - $331,448	-4,140 Reduced 4.54%	87,058 $6.96 Million
Q1 2019 Apr 12, 2019	BUY	$66.22 - $80.06 $6.04 Million - $7.3 Million	91,198 New	91,198 $6.6 Million

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.5 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.2 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.89 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.62 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.18 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account